GOODRX HOLDINGS INC
NASDAQ: GDRX (GoodRx Holdings, Inc.)
Last update: 23 hours ago3.11
-0.05 (-1.58%)
| Previous Close | 3.16 |
| Open | 3.10 |
| Volume | 3,433,821 |
| Avg. Volume (3M) | 4,953,082 |
| Market Cap | 1,055,636,672 |
| Price / Earnings (TTM) | 38.88 |
| Price / Earnings (Forward) | 10.29 |
| Price / Sales | 2.13 |
| Price / Book | 2.43 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 3.57% |
| Operating Margin (TTM) | 13.69% |
| Diluted EPS (TTM) | 0.070 |
| Quarterly Revenue Growth (YOY) | 2.60% |
| Quarterly Earnings Growth (YOY) | -88.60% |
| Total Debt/Equity (MRQ) | 82.71% |
| Current Ratio (MRQ) | 5.22 |
| Operating Cash Flow (TTM) | 150.72 M |
| Levered Free Cash Flow (TTM) | 74.77 M |
| Return on Assets (TTM) | 4.26% |
| Return on Equity (TTM) | 4.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | GoodRx Holdings, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | 4.0 |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.80 |
|
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 12.51% |
| % Held by Institutions | 62.88% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Francisco Partners Management, Lp | 30 Jun 2025 | 60,078,184 |
| Lakewood Capital Management, Lp | 30 Jun 2025 | 4,157,274 |
| Silver Lake Group, L.L.C. | 30 Jun 2025 | 3,532,276 |
| Petrus Trust Company, Lta | 30 Jun 2025 | 3,098,559 |
| Technology Crossover Management X, Ltd. | 30 Jun 2025 | 1,653,566 |
| Rip Road Capital Partners Lp | 30 Jun 2025 | 1,610,768 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 4.00 (Mizuho, 28.62%) | Hold |
| 4.00 (UBS, 28.62%) | Hold | |
| Median | 4.00 (28.62%) | |
| Average | 4.00 (28.62%) | |
| Total | 2 Hold | |
| Avg. Price @ Call | 3.16 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Mizuho | 06 Nov 2025 | 4.00 (28.62%) | Hold | 3.16 |
| UBS | 06 Nov 2025 | 4.00 (28.62%) | Hold | 3.16 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BEZDEK TREVOR | 3.37 | - | 33,530 | 112,996 |
| HIRSCH DOUGLAS JOSEPH | - | - | 0 | 0 |
| WAGNER SCOTT | 3.37 | - | 3,065 | 10,329 |
| Aggregate Net Quantity | 36,595 | |||
| Aggregate Net Value ($) | 123,325 | |||
| Aggregate Avg. Buy ($) | 3.37 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BEZDEK TREVOR | Director | 02 Nov 2025 | Acquired (+) | 33,530 | 3.37 | 112,996 |
| WAGNER SCOTT | Director | 31 Oct 2025 | Acquired (+) | 3,065 | 3.37 | 10,329 |
| HIRSCH DOUGLAS JOSEPH | Director | 26 Oct 2025 | Option execute | 20,521 | - | - |
| Date | Type | Details |
|---|---|---|
| 04 Nov 2025 | Announcement | GoodRx Reports Third Quarter 2025 Results |
| 15 Oct 2025 | Announcement | GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment |
| 08 Oct 2025 | Announcement | GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call |
| 06 Oct 2025 | Announcement | GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings |
| 01 Oct 2025 | Announcement | GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy |
| 02 Sep 2025 | Announcement | GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing |
| 18 Aug 2025 | Announcement | GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |